Where does Zaklady Farmaceutyczne Polpharma S.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Zaklady Farmaceutyczne Polpharma S.A. ranks #44,211 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Zaklady Farmaceutyczne Polpharma S.A. hold?

Zaklady Farmaceutyczne Polpharma S.A. holds 6 US utility patents granted between 2017 and 2025, spanning 5 technology areas.

What is Zaklady Farmaceutyczne Polpharma S.A.'s Innovation Score?

Zaklady Farmaceutyczne Polpharma S.A. has an Innovation Score of 24.2 out of 100 (14th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Zaklady Farmaceutyczne Polpharma S.A. focus on?

Zaklady Farmaceutyczne Polpharma S.A.'s top technology area is C07D (Heterocyclic Compounds) with 4 patents. Grants appear in 5 CPC subclasses total.

Is Zaklady Farmaceutyczne Polpharma S.A.'s patent grant rate increasing or decreasing?

Zaklady Farmaceutyczne Polpharma S.A.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Zaklady Farmaceutyczne Polpharma S.A.'s patents?

Zaklady Farmaceutyczne Polpharma S.A.'s patents average 16.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Zaklady Farmaceutyczne Polpharma S.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Zaklady Farmaceutyczne Polpharma S.A.

USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Zaklady ranks #44,211 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.

#44,211
of 49,997 US assignees by volume: 14th percentile
by Innovation Score (24.2/100): 16.0
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R44211 · Foreign Corporation #44,211 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #44,211/49,997
PHOTO-FINISH Zahroof Valves
CPC-NARROW C07D · 5 areas
INNOV-THIN 24.2/100
CLAIMS-RICH 16.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Zahroof Valves Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Zaklady Farmaceutycz… · this assignee

24
Gene Therapy Systems · near

24
Bioamber · near

24
Granite Tactical… · near

24
Structural Wrap · near

24
3D Lighting… · lowest

7

What this shows Zaklady's Innovation Score is 24.2/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Zaklady's grants concentrate

Zaklady Farmaceutyczne Polpharma S.A. is a focused PatentsView assignee: 5 CPC subclasses with 66.7% of grants classified under C07D (Heterocyclic Compounds). By volume, Zaklady sits between ZT (Guangdong) Night Vision Co., Ltd. and Zee Company I, LLC.

ZT (Guangdong) Ni…

6
Zuma Innovation S…

6
Zumax Medical

6
Zahroof Valves

6
Zap Energy

6
Zarbee's

6
Zedel

6
Zee I

6
Zaklady Farmaceut… ◀

6

What this shows Zaklady holds 6 patents at rank #44,205, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Zaklady

By rank, the assignees closest to #44,205 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Zaklady's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Zaklady, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (24 here).

Gene Therapy Systems, Inc. 24 Bioamber Inc. 24 Granite Tactical Vehicles Inc. 24 Structural Wrap, LLC 24

Zaklady's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 14th percentile higher than 14% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Zaklady Farmaceutyczne Polpharma S.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	16.7%
2018	1	16.7%
2020	1	16.7%
2021	1	16.7%
2025partial year	2	33.3%

Which technologies does Zaklady Farmaceutyczne Polpharma S.A. patent most?

C07D - Heterocyclic Compounds 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#44,211

of 49,997 tracked assignees

Innovation Score

24.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Zaklady Farmaceutyczne Polpharma S.A.'s patent record in context - here's where to go next.

Zaklady Farmaceutyczne Polpharma S.A.'s lead technology class is C07D (Heterocyclic Compounds), 66.7% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #44,211 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Zaklady Farmaceutyczne Polpharma S.A. against ZT (Guangdong) Night Vision Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.